Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: Retrospective study in 33 patients

Leukemia and Lymphoma

Volumn 54, Issue 4, 2013, Pages 807-811

  Helbig, Grzegorz ^a   Wiśniewska Piaty, Katarzyna ^a   Francuz, Tomasz ^a   Dziaczkowska Suszek, Joanna ^a   Kyrcz Krzemień, Sławomira ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Corticosteroids; Hypereosinophilia; Idiopathic hypereosinophilic syndrome; Response

Indexed keywords

CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HYDROXYUREA; IMATINIB; PREDNISONE; RECOMBINANT ALPHA INTERFERON; VINCRISTINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; BONE PAIN; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPHAGIA; EOSINOPHIL; EOSINOPHILIA; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; MAINTENANCE DRUG DOSE; MALAISE; MALE; MONOTHERAPY; MYALGIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SPLENOMEGALY; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL DISORDER; WEIGHT GAIN;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; EOSINOPHILS; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879528936     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.731602     Document Type: Article

References (18)

1. Teff eri A, Patnaik MM, Pardanani A. Eosinophilia:secondary, clonal and idiopathic. Br J Haematol 2006; 133: 468-492.
2. Walsh GM. Advances in the immunobiology of eosinophils and their role in disease. Crit Rev Clin Lab Sci 1999; 36: 453-496.
3. Helbig G, Kyrcz-Krzemie ń S. Diagnostic and therapeutic management in patients with hypereosinophilic syndrome. Pol Arch Med Wewn 2011; 121: 44-52.
4. Chusid MJ, Dale CD, West BC, et al. The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1-27.
5. Valent P, Klion A, Horny H P, et al. Contemprorary consensus proposal on criteria and classifi cation of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130: 607-612.
6. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759-2779.
7. Ogbogu PU, Bochner BS, Butterfi eld JH, et al. Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009; 121: 1319-1325.
8. Klion AD, Bochner BS, Gleich GJ. Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report. J Allergy Clin Immunol 2006; 117: 1292-1302.
9. Roufosse F. Hypereosinophilic syndrome variants: Diagnostic and therapeutic considerations. Haematologica 2009; 94: 1188-1193.
10. Valent P, Gleich G J, Reiter A, et al. Pathogenesis and classifi cation of eosinophil disorders: A review of recent developments in the fi eld. Expert Rev Hematol 2012; 159: 1-5.
11. Helbig G, Moskwa A, Hus M, et al. Heterogeneity among characteristics of hypereosinophilic syndromes. J Allergy Clin Immunol 2010; 125: 1399-1400.
12. Rothenberg ME, Klion AD, Roufosse F, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008; 358: 1215-1228.
13. Sheikh J, Weller PF. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007; 27: 333-355.
14. Helbig G, Hus M, Ha ł asz M, et al. Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRA-negative hypereosinophilic syndrome. Med Oncol 2012; 29: 1073-1076.
15. Jain N, Cortes J, Quintas-Cardama A, et al. Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown and negative PDGFRA mutation status. Leuk Res 2009; 33: 837-839.
16. Baccarani M, Cilloni D, Rondoni M, et al. The Efficacy of imatinib mesylate in patients with FIP1L1-PDGFR 〈 -positive hypereosinophilic syndrome. Results of multicenter prospective study. Haematologica 2007; 92: 1173-1179.
17. Bush RK, Geller M, Busse WW, et al. Response to corticosteroids in the hypereosinophilic syndrome: Association with increased serum IgE levels. Arch Intern Med 1978; 138: 1244-1246.
18. Teff eri A, Gotlib J, Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia: Point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 2010; 85: 158-164.